Jesús Troya Selected Research

Jesús Troya Research Topics

7	COVID-19 01/2023 - 11/2020
4	Infections 06/2019 - 01/2008
2	Virus Diseases (Viral Diseases) 01/2022 - 04/2021
2	Pneumonia (Pneumonitis) 01/2021 - 01/2021
2	HIV Infections (HIV Infection) 01/2020 - 07/2016
2	Reinfection 10/2019 - 01/2019
1	Lymphadenopathy 06/2023
1	Neoplasms (Cancer) 01/2022
1	Hepatitis C 10/2021
1	Opioid-Related Disorders (Opiate Addiction) 07/2021
1	Melanoma (Melanoma, Malignant) 04/2021
1	Hepatitis B 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Immune Reconstitution Inflammatory Syndrome 01/2017
1	Chronic Disease (Chronic Diseases) 07/2016
1	Gilbert Disease 07/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2008
1	Visceral Leishmaniasis (Kala Azar) 01/2008

4	AutoantibodiesIBA 01/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2015
2	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2019
2	Hepatitis C AntibodiesIBA 10/2021 - 01/2021
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 06/2023
1	dolutegravirIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 07/2021
1	InterferonsIBA 04/2021
1	HLA-C Antigens (HLA-C)IBA 04/2021
1	InflammasomesIBA 04/2021
1	AntibodiesIBA 01/2021
1	CoagulantsIBA 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021
1	Interferon Type IIBA 01/2021
1	CytokinesIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2020
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Biosimilar PharmaceuticalsIBA 01/2017
1	Infliximab (Remicade)FDA Link 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	abacavir (Ziagen)FDA Link 12/2016
1	Reverse Transcriptase InhibitorsIBA 07/2015
1	Surface Antigens (Surface Antigen)IBA 07/2015
1	Lamivudine (Epivir)FDA Link 07/2015
1	Ritonavir (Norvir)FDA Link 07/2015
1	Atazanavir Sulfate (Reyataz)FDA Link 07/2015
1	miltefosine (Impavido)IBA 01/2008

5	Therapeutics 07/2021 - 07/2015
2	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 07/2015